FIRST AIRED: June 17, 2015

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

×

Transcript

00:00:00
the company that wiped unsightly wrinkles off millions around the world has a new target the dreaded double chin botox maker allergan agreed on wednesday to buy chi sara biopharmaceuticals as it readies a new injection aimed at cutting chicken fat , the injection called chi bella is the first and only non surgical treatment to stifle that sagging unwanted ripple the fact that so many people face , the price tag two point one billion dollars which breaks down to our organs paying seventy five dollars a share for chi sara a roughly twenty four percent premium took my fair share price at tuesday's market close , the deal is elegans first multi billion dollar acquisition since it was bought by drug maker activist last year , chi bella works by shooting a synthetic acid under the skin destroying fat cells while leaving the surrounding tissue unaffected , no price tags been revealed yet for the injection but chances are it's cheaper than liposuction which for double chins cost between twenty seven hundred dollars to upwards of five grand